Wintershall Dea to Write Off $1 Billion Nord Stream 2 Financing
(Bloomberg) -- Wintershall Dea AG will write off its financing of the Nord Stream 2 natural gas pipeline project as pressure grows on energy companies to exit business interests connected to Russia in response to the invasion of Ukraine.
The German oil and gas producer, jointly owned by BASF SE and Russian billionaire Mikhail Fridman's investment firm LetterOne, will write off around 1 billion euros ($1.1 billion), it said Wednesday in a statement. It has also decided to postpone dividends following the move.
Wintershall Dea “remains involved” in the existing Yuzhno Russkoye and Achimov gas projects in Siberia, it said, adding that those joint ventures with the state-run gas giant Gazprom PJSC produce the vital fuel for the European market. Yet, the company decided “to basically stop payments to Russia with immediate effect,” and it won't pursue new projects in the country.
First BP, Now Shell: Big Oil Walks Away After Decades in Russia
In a matter of days, several energy companies have set out plans to exit Russian investments at a likely cost of tens of billions of dollars, upending relationships with Moscow that have been cultivated over decades. Some, like Shell Plc or Exxon Mobil Corp., have decided to ditch investments in Russia altogether, while France's TotalEnergies SE will no longer provide capital for new projects in the country.
The Nord Stream 2 link was completed in December, but its approval process was virtually stopped after the invasion. Gazprom is the sole owner of the link, though five European energy companies -- Shell, Wintershall, OMV AG, Engie SA and Uniper SE -- provided loans to finance the $11 billion project.
“The terrible events in Ukraine caused by the Russian invasion have sent shockwaves around the world,” Wintershall Dea Chief Financial Officer Paul Smith said in a statement. “And given the unprecedented uncertainty the company has decided to postpone the decision on the distribution of a dividend until further notice.”
©2022 Bloomberg L.P.
With assistance from Bloomberg
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
